Skip to main content
. 2018 Mar 14;9:169. doi: 10.3389/fphys.2018.00169

Figure 4.

Figure 4

Nitric oxide bioavailability and systemic vascular function. Nitric oxide (NO) bioavailability was determined by plasma levels of nitrates (A) and passive limb movement induced hyperemia normalized for muscle volume (ΔPLM; B). Systemic vascular function determined via ΔPLM/muscle volume is represented in (B) in healthy young (YG) and healthy old (OLD) controls, patients with mild cognitive impairment (MCI), and with different severity of AD, namely mild AD (AD1), moderate AD (AD2), and severe AD (AD3). Data are presented as mean ±S.E.; *Significantly different vs. YG group. Significantly different vs. OLD group. Significantly different vs. MCI group. §Significantly different vs. AD1 group. #Significantly different vs. AD2 group.